Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators?
The asymmetric methylarginines inhibit nitric oxide synthesis in vivo by competing with L-
arginine at the active site of nitric oxide synthase. High circulating levels of asymmetric …
arginine at the active site of nitric oxide synthase. High circulating levels of asymmetric …
Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators?
B Caplin, J Leiper - Arteriosclerosis, thrombosis, and …, 2012 - pubmed.ncbi.nlm.nih.gov
The asymmetric methylarginines inhibit nitric oxide synthesis in vivo by competing with L-
arginine at the active site of nitric oxide synthase. High circulating levels of asymmetric …
arginine at the active site of nitric oxide synthase. High circulating levels of asymmetric …
[HTML][HTML] Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators?
B Caplin, J Leiper - Arteriosclerosis, Thrombosis, and Vascular …, 2012 - europepmc.org
The asymmetric methylarginines inhibit nitric oxide synthesis in vivo by competing with L-
arginine at the active site of nitric oxide synthase. High circulating levels of asymmetric …
arginine at the active site of nitric oxide synthase. High circulating levels of asymmetric …
[HTML][HTML] Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators and regulators?
B Caplin, J Leiper - Arteriosclerosis, thrombosis, and vascular …, 2012 - ncbi.nlm.nih.gov
The asymmetric methylarginines inhibit nitric oxide synthesis in vivo by competing with L-
arginine at the active site of nitric oxide synthase. High circulating levels of asymmetric …
arginine at the active site of nitric oxide synthase. High circulating levels of asymmetric …
Brief Review
B Caplin, J Leiper - Arterioscler Thromb Vasc Biol, 2012 - Am Heart Assoc
The asymmetric methylarginines inhibit nitric oxide synthesis in vivo by competing with L-
arginine at the active site of nitric oxide synthase. High circulating levels of asymmetric …
arginine at the active site of nitric oxide synthase. High circulating levels of asymmetric …
[引用][C] Endogenous Nitric Oxide Synthase Inhibitors in the Biology of Disease: Markers, Mediators, and Regulators?
B CAPLIN, J LEIPER - Arteriosclerosis, thrombosis, and …, 2012 - pascal-francis.inist.fr
Endogenous Nitric Oxide Synthase Inhibitors in the Biology of Disease: Markers, Mediators,
and Regulators? CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
and Regulators? CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
Endogenous Nitric Oxide Synthase Inhibitors in the Biology of Disease Markers, Mediators, and Regulators?
B Caplin, J Leiper - Arteriosclerosis, Thrombosis, and Vascular …, 2012 - hero.epa.gov
The asymmetric methylarginines inhibit nitric oxide synthesis in vivo by competing with L-
arginine at the active site of nitric oxide synthase. High circulating levels of asymmetric …
arginine at the active site of nitric oxide synthase. High circulating levels of asymmetric …
Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators?
B Caplin, J Leiper - Arteriosclerosis, Thrombosis, and Vascular …, 2012 - eprints.gla.ac.uk
The asymmetric methylarginines inhibit nitric oxide synthesis in vivo by competing with L-
arginine at the active site of nitric oxide synthase. High circulating levels of asymmetric …
arginine at the active site of nitric oxide synthase. High circulating levels of asymmetric …
Endogenous Nitric Oxide Synthase Inhibitors in the Biology of Disease
B Caplin, J Leiper - Arteriosclerosis, Thrombosis, and Vascular Biology, 2012 - cir.nii.ac.jp
抄録< jats: p> The asymmetric methylarginines inhibit nitric oxide synthesis in vivo by
competing with L-arginine at the active site of nitric oxide synthase. High circulating levels of …
competing with L-arginine at the active site of nitric oxide synthase. High circulating levels of …
Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators?
B Caplin, J Leiper - Arteriosclerosis, Thrombosis, and Vascular …, 2012 - europepmc.org
The asymmetric methylarginines inhibit nitric oxide synthesis in vivo by competing with L-
arginine at the active site of nitric oxide synthase. High circulating levels of asymmetric …
arginine at the active site of nitric oxide synthase. High circulating levels of asymmetric …